Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- Check7 days agoChange DetectedTimestamp-related fields such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-17, 2025-11) were updated. No changes were made to the study content, arms, or eligibility criteria.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Updated the revision tags to v3.3.2 and v3.2.0 in the Publications sections.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the banner notice about a lapse in government funding from the page; the study details and supporting information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant changes detected between the two screenshots; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference1%

- Check78 days agoChange DetectedUpdated software revision from v3.0.2 to v3.1.0, indicating a new version release.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.